Abstract
Positron emission tomography (PET) represents the most advanced scintigraphic imaging technology. This technology is being employed for cardiovascular research as well as for clinical applications in patients with various cardiovascular diseases. Together with a considerable number of radiopharmaceuticals, PET allows the noninvasive assessment of myocardial perfusion, myocardial substrate metabolism, and cardiac innervation. This article will briefly review the various aspects of scintigraphic tissue characterization provided by this technology in the heart.
| Original language | English |
|---|---|
| Pages (from-to) | 1029-1034 |
| Number of pages | 6 |
| Journal | Therapeutic Innovation and Regulatory Science |
| Volume | 31 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1997 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular research
- Positron emission tomography
Fingerprint
Dive into the research topics of 'Cardiovascular positron emission tomography: A possible tool for assessment of new pharmaceuticals'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver